Each register and historical list with its number of registrations and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
PHARMAC (NZ funding schedule) · 5 registrations
HSA · 1 registration
TFDA · 1 registration
MS · 2 registrations · Historical list
Human medicines from every register that match Prochlorperazine by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
40 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Prochlorperazine | United States | 2.5MG, 25MG, 5MG | suppository | Marketed | Cosette |
| Prochlorperazine | United States | 10MG BASE, 25MG BASE, 5MG BASE | tablet | Not marketed | Watson Labs |
| Prochlorperazine | United States | 5MG BASE/ML | injectable | Not marketed | Baxter Hlthcare |
| Prochlorperazine | United States | 10MG BASE/ML | concentrate | Not marketed | Alpharma US Pharms |
| Prochlorperazine Maleate | United States | 10MG BASE, 25MG BASE, 5MG BASE | tablet | Marketed | DR Reddys Labs SA |
| Prochlorperazine maleate (Brown & Burk) | New Zealand | Tab 3 mg buccal | Funded | ||
| Odan-Prochlorperazine | Canada | 10 MG | Suppository | Marketed | Odan Laboratoriesltd |
| Prochlorperazine Edisylate | United States | 5MG BASE/ML | injectable | Marketed | Watson Labs |
| Procomp | United States | 10MG BASE, 5MG BASE | tablet | Marketed | Jubilant Cadista |
| Prochlorperazine Edisylate | United States | 10MG BASE/ML | concentrate | Not marketed | Morton Grove |
| Prochlorperazine Edisylate | United States | 5MG BASE/5ML | syrup | Not marketed | Morton Grove |
| Prochlorazine | Canada | 10 MG | Tablet | Marketed | Aa Pharma INC |
| Prochlorazine | Canada | 5 MG | Tablet | Marketed | Aa Pharma INC |
| Compro | United States | 25MG | suppository | Marketed | Padagis US |
| Compazine | United States | 10MG BASE, 25MG BASE, 5MG BASE | tablet | Not marketed | Glaxosmithkline |
| Compazine | United States | 10MG BASE, 15MG BASE, 30MG BASE … | capsule, extended release | Not marketed | Glaxosmithkline |
| Compazine | United States | 2.5MG, 25MG, 5MG | suppository | Not marketed | Glaxosmithkline |
| PROCHLOR TABLETS 5 mg | Singapore | 5 mg | tablet | Authorised | Beacons Pharmaceuticals Pte. LTD. |
| Any | New Zealand | Tab buccal 3 mg | Funded | ||
| Any | New Zealand | Inj 12.5 mg per ml, 1 ml ampoule | Funded | ||
| Nausafix | New Zealand | Tab 5 mg | Funded | ||
| Stemetil | New Zealand | Inj 12.5 mg per ml, 1 ml | Funded | ||
| Compazine | United States | 5MG BASE/ML | injectable | Not marketed | Glaxosmithkline |
| Compazine | United States | 5MG BASE/5ML | syrup | Not marketed | Glaxosmithkline |
| Compazine | United States | 10MG BASE/ML | concentrate | Not marketed | Glaxosmithkline |
The same brand on several registers.
The companies holding its medicines, the most first.
Substances it shares a medicine with.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of FDA, Health Canada, HSA, MS, PHARMAC (NZ funding schedule) and TFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
